Skip to main content
Top
Published in: Journal of General Internal Medicine 10/2010

01-10-2010 | Editorial

The New Heart Failure Diet: Less Salt Restriction, More Micronutrients

Authors: Michael B. Rothberg, MD, MPH, Senthil K. Sivalingam, MD

Published in: Journal of General Internal Medicine | Issue 10/2010

Login to get access

Excerpt

The Western diet has been implicated in a number of chronic diseases, including heart disease, diabetes and cancer. Patients have eagerly sought medical guidance on the proper diet, and although certain food elements appear to increase the risk of certain diseases, offering up specific dietary advice can be a treacherous endeavor. For one thing, diet is notoriously difficult to study. The effects of diet may take years to develop, few volunteers are willing to engage in randomized trials of diet for long periods of time, and protective factors identified in cohort studies rarely stand up to randomized trials. Not surprisingly, diet advice predicated on observational studies or pathophysiological mechanisms rather than randomized trial evidence may turn out to be ineffective (e.g. avoiding eggs)1 or even harmful (e.g. replacing the saturated fat in butter with margarine rich in trans-fats).2
Literature
1.
go back to reference Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999;281:1387–1394.CrossRefPubMed Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999;281:1387–1394.CrossRefPubMed
2.
go back to reference Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–1613.CrossRefPubMed Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans fatty acids and cardiovascular disease. N Engl J Med. 2006;354:1601–1613.CrossRefPubMed
3.
go back to reference Gotto AM Jr, Bierman EL, Connor WE, et al. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Circulation. 1984;69:1065A–1090A.PubMed Gotto AM Jr, Bierman EL, Connor WE, et al. Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis. Circulation. 1984;69:1065A–1090A.PubMed
4.
go back to reference Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.CrossRefPubMed Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69.CrossRefPubMed
5.
go back to reference Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011–1020.CrossRefPubMed Johnson RK, Appel LJ, Brands M, et al. Dietary sugars intake and cardiovascular health: a scientific statement from the American Heart Association. Circulation. 2009;120:1011–1020.CrossRefPubMed
6.
go back to reference Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–28.CrossRefPubMed Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009;360:1418–28.CrossRefPubMed
7.
go back to reference Tsuyuki RT, McKelvie RS, Arnold JM, et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001;161:2337–42.CrossRefPubMed Tsuyuki RT, McKelvie RS, Arnold JM, et al. Acute precipitants of congestive heart failure exacerbations. Arch Intern Med. 2001;161:2337–42.CrossRefPubMed
8.
go back to reference Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1–82.CrossRefPubMed Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2005;46:e1–82.CrossRefPubMed
10.
go back to reference Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol. 2000;278:F585–95.PubMed Heer M, Baisch F, Kropp J, Gerzer R, Drummer C. High dietary sodium chloride consumption may not induce body fluid retention in humans. Am J Physiol Renal Physiol. 2000;278:F585–95.PubMed
11.
go back to reference Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008;114:221–30.CrossRef Paterna S, Gaspare P, Fasullo S, Sarullo FM, Di Pasquale P. Normal-sodium diet compared with low-sodium diet in compensated congestive heart failure: is sodium an old enemy or a new friend? Clin Sci (Lond). 2008;114:221–30.CrossRef
12.
go back to reference Paterna S, Parrinello G, Cannizzaro S, et al. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009;103:93–102. Epub 2008 Oct 17.CrossRefPubMed Paterna S, Parrinello G, Cannizzaro S, et al. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure. Am J Cardiol. 2009;103:93–102. Epub 2008 Oct 17.CrossRefPubMed
13.
go back to reference Alsafwah S, Laguardia SP, Arroyo M, et al. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res. 2007;5:238–43.CrossRefPubMed Alsafwah S, Laguardia SP, Arroyo M, et al. Congestive heart failure is a systemic illness: a role for minerals and micronutrients. Clin Med Res. 2007;5:238–43.CrossRefPubMed
14.
go back to reference Witte KK, Nikitin NP, Parker AC, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005;26:2238–44. Epub 2005 Aug 4.CrossRefPubMed Witte KK, Nikitin NP, Parker AC, et al. The effect of micronutrient supplementation on quality-of-life and left ventricular function in elderly patients with chronic heart failure. Eur Heart J. 2005;26:2238–44. Epub 2005 Aug 4.CrossRefPubMed
15.
go back to reference Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009;302:2254–6.CrossRefPubMed Kent DM, Trikalinos TA. Therapeutic innovations, diminishing returns, and control rate preservation. JAMA. 2009;302:2254–6.CrossRefPubMed
Metadata
Title
The New Heart Failure Diet: Less Salt Restriction, More Micronutrients
Authors
Michael B. Rothberg, MD, MPH
Senthil K. Sivalingam, MD
Publication date
01-10-2010
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 10/2010
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-010-1254-8

Other articles of this Issue 10/2010

Journal of General Internal Medicine 10/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine